I now have sufficient information to give a thorough clinical interpretation. Here is the full analysis:
Lab Report Interpretation — Miss Zarka Lateef, 29F (Collected 12 May 2026)
🔴 Abnormal Results at a Glance
| Test | Result | Reference | Status |
|---|
| TSH | 5.454 µIU/mL | 0.38–5.33 | ⬆ HIGH |
| ALT (SGPT) | 49.50 U/L | 0–33 | ⬆ HIGH |
| Total Protein | 8.33 g/dL | 6.4–8.3 | ⬆ marginally high |
| Globulin | 3.75 g/dL | 2.4–3.5 | ⬆ marginally high |
| All other LFTs | Within range | — | ✅ Normal |
1. TSH = 5.454 µIU/mL (Mildly Elevated) → Subclinical Hypothyroidism
What this means
TSH is just above the upper limit of normal (5.33), with no Free T4 or Free T3 reported. This pattern is consistent with subclinical (early/mild) primary hypothyroidism — the thyroid gland is underperforming slightly, so the pituitary compensates by secreting more TSH, but circulating thyroid hormones remain in range.
What to do
Step 1 — Repeat and confirm
"It is important to confirm that any elevation of TSH is sustained over a 3-month period before treatment is given." — Harrison's Principles of Internal Medicine 22e
Do not treat on a single result. Order a repeat TSH + Free T4 in 6–8 weeks to confirm persistence.
Step 2 — Essential additional workup
- Free T4 (if not previously measured — not included in this panel)
- Anti-TPO antibodies (thyroid peroxidase antibodies) — positive titers support Hashimoto thyroiditis as the underlying cause and increase the likelihood of progression to overt hypothyroidism
- Ask about symptoms: fatigue, cold intolerance, weight gain, constipation, dry skin, menstrual irregularities, depression
Step 3 — Treat or monitor?
Per Harrison's and Goldman-Cecil Medicine:
| Scenario | Recommendation |
|---|
| TSH 5–10, no symptoms, no anti-TPO | Annual monitoring (repeat TSH + FT4 yearly) |
| TSH 5–10 + symptoms suggestive of hypothyroidism | Trial of LT4 (levothyroxine 25–50 µg/day, titrate to normalize TSH) |
| TSH 5–10 + elevated anti-TPO antibodies | Consider treatment (higher risk of progression) |
| TSH > 10 mIU/L | Treat regardless |
| Planning pregnancy / pregnant | Treat — target TSH < 2.5 µIU/mL |
For this 29-year-old woman — since she is of reproductive age, pregnancy intentions must be specifically asked. If she is planning conception, treat now to achieve TSH < 2.5 µIU/mL before conception. The lab's own pregnancy reference ranges (1st trimester: 0.1–2.5; 2nd/3rd: 0.2–3.0) confirm her current TSH would be elevated in pregnancy.
2. ALT = 49.50 U/L (Mildly Elevated, ~1.5× ULN)
What this means
ALT is the most liver-specific aminotransferase. A mild elevation (< 5× ULN) with ALT > AST (as here: ALT 49.5 vs AST 30.6 — both near normal range) is most commonly seen with:
- Non-alcoholic fatty liver disease (NAFLD/MASLD) — most common cause of mildly elevated unexplained ALT
- Chronic viral hepatitis (B or C)
- Drug/supplement-induced (review all medications, supplements, herbal products)
- Autoimmune hepatitis, hemochromatosis, Wilson's disease (less common)
- Note: Hypothyroidism itself can mildly elevate transaminases via hepatic metabolic effects — the two findings may not be unrelated
Per Textbook of Family Medicine 9e: "Probably the most common cause of persistently elevated unexplained aminotransferase is fatty infiltration of the liver."
What to do
- Repeat LFT in 4–6 weeks to confirm persistence
- Hepatitis B surface antigen (HBsAg) + Anti-HCV screening
- Fasting lipid profile + fasting glucose/HbA1c (metabolic workup for NAFLD)
- Abdominal ultrasound — assess for hepatic steatosis
- Review and stop any potentially hepatotoxic medications or herbal supplements
- If BMI is elevated → lifestyle modification (diet and exercise) — this alone can normalize ALT in NAFLD
3. Marginally Elevated Total Protein (8.33) and Globulin (3.75)
Both are only slightly above the upper reference limit. The albumin (4.58) and A/G ratio (1.22 — normal) are reassuring; this does not suggest hypoalbuminemia or synthetic liver dysfunction. Mildly raised globulin is nonspecific and can be seen with chronic inflammation, infections, or autoimmune conditions. No immediate intervention required, but:
- Recheck with repeat LFT
- If globulin remains elevated: consider serum protein electrophoresis (SPEP)
Summary Action Plan
| Priority | Action |
|---|
| Now | Repeat TSH + Free T4 in 6–8 weeks |
| Now | Add Anti-TPO antibodies |
| Now | HBsAg, Anti-HCV |
| Now | Fasting glucose, HbA1c, lipid profile |
| Now | Abdominal ultrasound (liver) |
| Soon | Detailed history: symptoms of hypothyroidism, alcohol, medications, supplements, family thyroid history, pregnancy plans |
| If confirmed hypothyroid + indicated | Start levothyroxine 25–50 µg/day |
| Annual | If not treating, monitor TSH + FT4 yearly |
⚠️ Disclaimer: This is a clinical interpretation for educational/advisory purposes. All management decisions should be made in the context of the full clinical examination, patient history, and physician judgment. This is not a substitute for an in-person medical consultation.